Remove Manufacturing Remove Pharma Remove Pharmaceutical manufacturing
article thumbnail

Key developments in pharmaceutical manufacturing – September 2023

European Pharmaceutical Review

September 2023 saw a wave of new pharmaceutical manufacturing facility expansions and launches across Europe. Importantly, each site features advanced technologies to support development and manufacture of these therapeutics. Materials and financing costs are high and squeezing manufacturers and their customers alike.

article thumbnail

Why today’s leading pharma manufacturers are adopting proactive asset management strategies

PharmaVoice

In recent months, high-profile drug shortages have brought pharmaceutical manufacturing operations into the spotlight.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharma Horizons: Sustainability

European Pharmaceutical Review

This report delves into the latest developments in sustainability impacting the pharmaceutical sector today. Inside, articles explore current key topics including regulation, manufacturing, green chemistry, digitalisation and clinical trials. Interested?

Pharma 59
article thumbnail

PhRMA lies to protect pharma profits

World of DTC Marketing

Such warnings “constitute the pharma response in literally every instance since 1906,” the first drug regulation agency was created, said Dr. Aaron Kesselheim. The post PhRMA lies to protect pharma profits appeared first on World of DTC Marketing.com. Amazon’s operating margin is under 5 percent.

Pharma 255
article thumbnail

Pharma unite to secure renewable energy in key manufacturing markets

European Pharmaceutical Review

This step is important as these countries are key markets for pharmaceuticals manufacturing. GSK propels its progress to Net Zero Renewable energy in the pharma supply chain The SMI Health Systems Task Force is a public-private partnership launched at COP26.

article thumbnail

Pharma Horizons: Artificial Intelligence

European Pharmaceutical Review

The first in our inaugural Pharma Horizons report series is dedicated to exploring the latest advances in artificial intelligence (AI) and machine learning (ML) for drug development, pharmaceutical manufacturing and quality control. Additionally the pharmaceutical AI market is projected to reach $11.8

Pharma 130
article thumbnail

As pharma abandons the antibiotic market patients are at risk

World of DTC Marketing

A pull strategy is needed with financial incentives to repair the broken market for antibiotics and make it worthwhile for the pharma industry to bring promising drugs to market. Pew Internet reminds us all that, above all, the pharma industry is a business. The pharma industry is warning of the consequences of inaction. “If

Marketing 174